Speaker Profile Thumbnail for Emmanuelle Charpentier

Nobel Prize-Winning Scientist | Co-Creator of CRISPR-Cas9 Gene Editing Technology | Speaker on Biotechnology and Genomic Innovation

Emmanuelle Charpentier Speaking Fee: $50,000 to $75,000

Nobel Prize-Winning Scientist | Co-Creator of CRISPR-Cas9 Gene Editing Technology | Speaker on Biotechnology and Genomic Innovation

Speaker Profile Thumbnail for Emmanuelle Charpentier
Speaking Fee:
$50,000 to $75,000

Travels From:
LON - London (All Airports)

Primary Topic Category:
Science (STEM / STEAM)

Secondary Topic Category:
Healthcare

 

Emmanuelle Charpentier Speaker Profile: At A Glance

Dr. Emmanuelle Charpentier is a distinguished microbiologist and geneticist, renowned for her pioneering work in CRISPR-Cas9 gene editing technology. She was awarded the Nobel Prize in Chemistry in 2020, becoming a leading figure in modern science for her transformative contributions to genome engineering. As a founder of the Max Planck Unit for the Science of Pathogens, Dr. Charpentier continues to drive forward research in molecular biology and infectious disease. Her insights have profoundly impacted biotechnology, medicine, and the broader scientific community. Join her to explore groundbreaking advancements at the intersection of genetic

Emmanuelle Charpentier is a renowned figure in the world of microbiology, best known for her groundbreaking work on the CRISPR-Cas9 gene-editing technology. Born in Juvisy-sur-Orge, France, in 1968, Charpentier developed a keen interest in biology at a young age. Her academic journey took her through some of the most prestigious institutions in Europe. She pursued her higher education at the Pierre and Marie Curie University and later completed her doctoral studies at the Pasteur Institute. Her postdoctoral research included stints at esteemed institutions such as The Rockefeller University in New York and the Skirball Institute of Biomolecular Medicine. Charpentier's illustrious career took a transformative turn with her discovery of how bacteria can defend themselves against viruses, a revelation that led to the development of CRISPR-Cas9. This technology allows for precise and targeted genetic modifications, revolutionizing fields ranging from medicine to agriculture. Her collaboration with Jennifer Doudna of the University of California, Berkeley, was pivotal. Together, they demonstrated how CRISPR-Cas9 could be used as a tool to edit the genomes of living organisms, setting the stage for innovations that were previously thought to be science fiction. Her contributions to science have not gone unnoticed. Charpentier was awarded the 2020 Nobel Prize in Chemistry alongside Doudna for their "development of a method for genome editing." This accolade added to her already impressive roster of awards, including the Breakthrough Prize in Life Sciences and numerous other honors. Her work has opened new avenues in research, offering potential cures for genetic disorders and advancing our understanding of genetics. Today, Emmanuelle Charpentier continues to push the boundaries of scientific knowledge. She is the Founding and Acting Director of the Max Planck Unit for the Science of Pathogens in Berlin. Her work not only centers around CRISPR technology but also explores other pivotal areas of microbiological research. Charpentier is deeply committed to inspiring future generations of scientists and actively advocates for women in science. Beyond the lab, Charpentier is known for her dedication to mentoring young researchers and fostering an environment of rigorous scientific inquiry. Her work, deeply rooted in curiosity and a desire to break new ground, continues to leave a significant impact on the scientific community and the world at large. Through her numerous speaking engagements and publications, she remains a thought leader in the field, sharing her insights and passion for science with audiences globally.
Gotham Artists